Features

The adoption of clinical pathways is standardizing the cancer care process, with adherence to established protocols impacting efficacy, safety, and cost of care. 
The authors share their experiences with implementing PRO collection and discuss the key considerations for success, including appropriate measure selection, achieving buy-in from health care providers, and utilizing PRO data in clinical practice.
As the Republican party gains control over federal health care policy, it seems likely that patients will have much more involvement in their health care.
The way in which health care is delivered must be rethought with a focus on care coordination, patient engagement, and specific treatments through clinical pathways.
Clinical pathways provide opportunities to facilitate a shift towards patients who have ownership of their treatment and behave as active consumers.
Despite the high incidence of diabetes, disease management remains elusive and the per patient costs have continued to escalate.
Clinical pathways for diabetes could grow by addressing cultural differences, low health literacy of patients and the need for innovative tools and products.
Clinical pathways provide an opportunity to aid the implementation of evidence-based practices for patients with diabetes in order to improve control of the disease, reduce the incidence of complications, and contain health care costs. 
In this article, the authors review theories of change management and explore how they can be applied to the implementation of clinical pathways.